In This Section

Program Page

Please note that this meeting will take place as an in-person event in San Diego, California and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise.  Program in progress.

*-Short talk from proffered abstract

SUNDAY, JANUARY 26

MONDAY, JANUARY 27

TUESDAY, JANUARY 28

WEDNESDAY, JANUARY 29

Sunday, January 26

REGISTRATION

2:30 -7 p.m.

WELCOME AND OPENING Keynote

6:15 -7 p.m. | CME Eligible

  • Michael Baumann, DFKZ German Cancer Research Center, Heidelberg, Germany 

Opening Reception

7 -9 p.m.

Monday, January 27

CONTINENTAL BREAKFAST

7 -8 a.m.

Plenary Session 1: FLASH

8-10 a.m. | CME Eligible

  • FLASH, an opportunity for the treatment of pediatric brain tumors or Transcriptional imprint of FLASH radiotherapy 
    Marie-Catherine Vozenin, Lausanne University Hospital, Lausanne, Switzerland 
  • Proton FLASH radiotherapy: How lessons from preclinical models inform clinical trials 
    Constantinos Koumenis, University of Pennsylvania, Philadelphia, Pennsylvania

Short talks from highly rated abstracts

BREAK

10-10:30 a.m.

Spotlight Session Topic to be Announced

11 a.m.- 12 p.m.

Lunch on own

12-1:30 p.m.

Plenary Session 2: Nodal management with immune check point therapy 

1:30-3:30 p.m. | CME Eligible

  • To treat or not to treat: Nodal irradiation in the context of immunotherapy
    Sana D. Karam, Washington University School of Medicine, St. Louis, Missouri
  • J. Sylvio Gutkind, University of California, San Diego, San Diego, California 
  • Quynh-Thu Le, Stanford Cancer Institute, Stanford, California

Short talks from highly rated abstracts

Break

3:30- 4 p.m.

Plenary Session 3:  Theragnostics and external beam 

4-6 p.m. | CME Eligible

  • Chemical strategies to expand the therapeutic window of targeted radiotherapies
    Michael Evans, University of California San Francisco, San Francisco, California
  • Rebecca K.S. Wong, UHN Princess Margaret Cancer Center, Toronto, ON, Canada

Short talks from highly rated abstracts

Poster Session A + Reception

6-7:30 p.m.

Tuesday, January 28

CONTINENTAL BREAKFAST

7 -8 a.m.

Plenary Session 4: AI in radiation therapy

8- 10 a.m. | CME Eligible

  • Clinical Implementation of AI in Radiation Therapy
    Steven B. Jiang, UT Southwestern, Dallas, Texas
  • Translating language models into the oncology clinic: Approaches for scalable evaluation and oversight 
    Danielle S. Bitterman, Dana-Farber Cancer Institute, Boston, Massachusetts

BREAK

10-10:30 a.m.

Proffered Talks 

10:30- 11:30 a.m. | CME Eligible

Lunch on own

11:30 a.m. – 1 p.m.

Plenary Session 5: Ferroptosis and radiation 

1-2:30 p.m. | CME Eligible

  • Targeting ferroptosis in radioresistance 
    Boyi Gan, The University of Texas MD Anderson Cancer Center, Houston, Texas
  •  Understanding ferroptosis molecular mechanisms to advance ferroptosis therapies in cancer 
    Scott Dixon, Stanford University, Stanford, California

Break

2:30- 2:45 p.m.

Plenary Session 6: Integrating DNA damage repair targeting with radiation therapy

2:45- 4:15 p.m. | CME Eligible

Plenary Session 7:  Role of radiation and cell therapy 

4:30 -6 p.m. | CME Eligible

  • Low-dose total body irradiation improves response to CAR T cell therapy 
    Monica L. Guzman, Weill Cornell Medical College, New York, New York

Poster Session B + Reception  

6-7:30 p.m.

Wednesday, January 29

CONTINENTAL BREAKFAST

7 -8 a.m.

Plenary Session 8: Update on radiation and immunotherapy

8-10 a.m. | CME Eligible

  • David G. Kirsch, UHN Princess Margaret Cancer Center, Toronto, Canada 
  • Silvia C. Formenti, Weill Cornell Medicine, New York, New York

Short talks from highly rated abstracts

BREAK

10-10:30 a.m.

KEynote

10:30- 11:15 a.m.

  • Radiotherapy immunotherapy interactions:  Determinants of success and failure 
    Ralph R. Weichselbaum, University of Chicago, Chicago, Illinois

Plenary Session 9: Emerging therapeutics or biomarkers for radiation therapy  

11:15 a.m.-12:45 p.m. | CME Eligible

  • Liquid biopsies for noninvasive detection and characterization of cancers
    Maximillian Diehn, Stanford University, Stanford, California
  • Albert C. Koong, The University of Texas MD Anderson Cancer Center, Houston, Texas

Closing Remarks and Departure

12:45 p.m.